Combination of Genetic and Quantitative Serological Immune Markers are Associated with Complicated Crohn’s Disease Behavior

BACKGROUND: Treatment of Crohn’s disease (CD) with biologics may alter disease progression, leading to fewer disease-related complications, but cost and adverse event profiles often limit their effective use. Tools identifying patients at high risk of complications, who would benefit the most from b...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lichtenstein, Gary R., Targan, Stephan R., Dubinsky, Marla C., Rotter, Jerome I., Barken, Derren M., Princen, Fred, Carroll, Susan, Brown, Michelle, Stachelski, Jordan, Chuang, Emil, Landers, Carol J., Stempak, Joanne M., Singh, Sharat, Silverberg, Mark S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4203682/
https://ncbi.nlm.nih.gov/pubmed/21391291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ibd.21661
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia